Furthermore, bleomycin-induced pulmonary fibrosis is mitigated by a global SPHK inhibitor or genetic deletion of Sphk1-/-, but not Sphk2-/- in mice [15]. Here, SPHK1 is linked to pulmonary fibrosis.